A UK-based phase I trial of recombinant modified vaccinia ankara (MVA) vaccine encoding Epstein-Barr virus (EBV) antigens
Invited conference paper presented and published in conference proceedings


Times Cited
Web of Science0WOS source URL (as at 13/06/2021) Click here for the latest count
Altmetrics Information
.

Other information
All Author(s) ListSTEVEN N M, HARRINGTON K J, LEE L, JIA H, TANDAY M K, ROBERTS C, EDWARDS C, MCGUIGAN L, HARTLEY A G J, VISKADURAKI M, HUI Edwin P, CHAN Anthony Tak Cheung, RICKINSON A B, TAYLOR G S
Name of Conference2011 ASCO Annual Meeting
Start Date of Conference03/06/2011
End Date of Conference07/06/2011
Place of ConferenceChicago, IL
Country/Region of ConferenceUnited States of America
Proceedings TitleJOURNAL OF CLINICAL ONCOLOGY
Year2011
Month5
Volume Number29
Issue NumberSuppl 15
PublisherAMER SOC CLINICAL ONCOLOGY
Place of PublicationUnited States of America
ISSN0732-183X
eISSN1527-7755
LanguagesEnglish-United Kingdom
KeywordsMVA, EBV

Last updated on 2021-14-06 at 01:30